A review on the role of carnitine in the management of tamoxifen side effects in treated women with breast cancer

被引：12
作者：
El-Ashmawy, Nahla E. [1 ]
Khalil, Rania M. [2 ]
机构：
[1] Tanta Univ, Dept Biochem, Fac Pharm, Tanta, Egypt
[2] Delta Univ, Dept Biochem, Fac Pharm, Gamasah, Egypt
来源：
TUMOR BIOLOGY | 2014年 / 35卷 / 04期
关键词：
Breast cancer; Cancer prognosis; L-carnitine; Resistance; Side effects; Tamoxifen; ACETYL-L-CARNITINE; RANDOMIZED DOUBLE-BLIND; PROPIONYL-L-CARNITINE; FATTY-ACID SYNTHASE; GROWTH-FACTOR-I; POSTMENOPAUSAL WOMEN; OXIDATIVE STRESS; DEPRESSED MOOD; HUMAN CORNEAL; FATIGUE;
D O I：
10.1007/s13277-013-1477-5
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
l-carnitine is an antioxidant and is found to be a protective agent against many diseases including cancer. This review illustrates the possible role of l-carnitine as an add-on therapy to breast cancer patients maintained on tamoxifen. The objectives of carnitine treatment are diverse: improving tamoxifen-related side effects, offering better cancer prognosis by reducing the risk of developing cancer recurrence or metastasis, and modulating the growth factors which may be, in part, a prospective illustration to overcome tamoxifen resistance. So, it could be recommended to supplement l-carnitine to breast cancer patients starting tamoxifen treatment.
引用
收藏
页码：2845 / 2855
页数：11
相关论文
共 50 条
  • [1] Profiles of tamoxifen-related side effects by race and smoking status in women with breast cancer
    Zhan, Min
    Flaws, Jodi A.
    Gallicchio, Lisa
    Tkaczuk, Katherine
    Lewis, Lynn M.
    Royak-Schaler, Renee
    CANCER DETECTION AND PREVENTION, 2007, 31 (05): : 384 - 390
  • [2] Tamoxifen Effects on Cognition and Language in Women with Breast Cancer
    Sharma, Saryu
    Wright, Heather Harris
    SEMINARS IN SPEECH AND LANGUAGE, 2023, 44 (03) : 189 - 202
  • [3] Effects of tamoxifen on cognition and language in women with breast cancer: A systematic search and a scoping review
    Jebahi, Fatima
    Sharma, Saryu
    Bloss, Jamie E.
    Wright, Heather H.
    PSYCHO-ONCOLOGY, 2021, 30 (08) : 1262 - 1277
  • [4] Ovarian cysts in tamoxifen-treated women with breast cancer
    Inal, MM
    Incebiyik, A
    Sanci, M
    Yildirim, Y
    Polat, M
    Pilanci, B
    Nayki, C
    Camuzcuoglu, H
    EUROPEAN JOURNAL OF OBSTETRICS GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2005, 120 (01): : 104 - 106
  • [5] Association of tamoxifen (TAM) and TAM metabolite concentrations with self-reported side effects of TAM in women with breast cancer
    Gallicchio, L
    Lord, G
    Tkaczuk, K
    Danton, M
    Lewis, LM
    Lim, CK
    Flaws, JA
    BREAST CANCER RESEARCH AND TREATMENT, 2004, 85 (01) : 89 - 97
  • [6] Association of Tamoxifen (TAM) and TAM Metabolite Concentrations with Self-Reported Side Effects of TAM in Women with Breast Cancer
    Lisa Gallicchio
    Gwyn Lord
    Katherine Tkaczuk
    Malcolm Danton
    Lynn M. Lewis
    Chang K. Lim
    Jodi A. Flaws
    Breast Cancer Research and Treatment, 2004, 85 : 89 - 97
  • [7] Tamoxifen with radiotherapy compared with Tamoxifen alone in elderly women with early-stage breast cancer treated with breast conserving surgery: A systematic review and meta-analysis
    Chesney, Tyler R.
    Yin, Jennifer Xin
    Rajaee, Nikoo
    Tricco, Andrea C.
    Fyles, Anthony W.
    Acuna, Sergio A.
    Scheer, Adena S.
    RADIOTHERAPY AND ONCOLOGY, 2017, 123 (01) : 1 - 9
  • [8] A review of the logistic role of l-carnitine in the management of radiation toxicity and radiotherapy side effects
    Khan, Haseeb Ahmad
    Alhomida, Abdullah Saleh
    JOURNAL OF APPLIED TOXICOLOGY, 2011, 31 (08) : 707 - 713
  • [9] Is screening for endometrial cancer necessary in asymptomatic women treated with tamoxifen for breast cancer?
    Ju, U. Chul
    Kang, Woo Dae
    Kim, Seok Mo
    EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2022, 43 (02) : 169 - 174
  • [10] Side Effects Associated with Ultrarapid Cytochrome P450 2D6 Genotype among Women with Early Stage Breast Cancer Treated with Tamoxifen
    Rolla, R.
    Vidali, M.
    Meola, S.
    Pollarolo, P.
    Fanello, M. R.
    Nicolotti, C.
    Saggia, C.
    Forti, L.
    Agostino, F. D.
    Rossi, V.
    Borra, G.
    Stratica, F.
    Alabiso, O.
    Bellomo, G.
    CLINICAL LABORATORY, 2012, 58 (11-12) : 1211 - 1218
12345